INCATE will be at @ESCMID ASM Conference!
Meet our colleague Derry Mercer - Head of AMR Programme at @BIOASTER . The event aims to address the threat of #AMR explore opportunities and define key criteria for drug development.
🗓 Sept 17-20.24
📍Porto, Portugal
#drugdevelopment
How do we go from virus detection to effective #vaccines for all?
How does this impact public health issues, e.g. #cancer?
Find out at the IARC & @mdc_confluences hosted event– Vaccination: a tool to prevent epidemics & cancer
Thurs 13/6, 6pm
Register here https://t.co/xMBOfwa72u
Le CIRC participera aux Fêtes consulaires 2024!
En collaboration avec @mdc_confluences, nous organisons la conférence internationale "La #vaccination comme outil de prévention des épidémies et du #cancer" le 13 juin au CIRC.
#FêtesConsulaires
Inscriptions: https://t.co/jrpZok1l5y
Interested in AI and technology development for infectious diseases and weren't able to login to BEAM Alliance 's first webinar hosted by @BIOASTER on "Novel technologies with an AI-facilitated approach" ?
No worries, the recording is now available👉 https://t.co/982U57h1Go
📢Webinar hosted by @AllianceBEAM: update on @BIOASTER and the integration of artificial intelligence and deep learning into antimicrobial R&D.
"Novel technologies with an AI-facilitated approach"
🗓 21.03.24
🕑 1pm-2pm
📍 Online
Register now ➡ https://t.co/YUzOl8GKEM
@INCATEurope (the INCubator for #Antibacterial Therapies in Europe) and BIOASTER, have announced this week the beginning of a new partnership that aims to improve the support to innovators to fight drug-resistant infections.
See the release here: https://t.co/tcGGbDqRkn
#AMR
[#LBPevent] A. Gordon from @imperialcollege, P. Lassale from Biothelis, N.Boulanger from @unistra, P. Leissner from @BIOASTER and A. Didierlaurent from @UNIGEnews will talk about diagnostic, prognostic and clinical biomarkers at the @I4IDCongress.
➡ https://t.co/KJcF76A8aL
@BIOASTER announce the set-up (1st installed in France!) firefly® robot ( @SPTLabtech ). It will simplify & standardize our #transcriptomics and #genomics workflows. Benefit to our partners: more samples will be processed in a standardized way and shortened time. #sequencing
📢 Meet our #microbiome program team (Dr. Thomas Leicht & Dr. Ilia Belotserkovsky ) at the next Microbiome R&D and #business#congress : ASIA in Seoul , South Korea.
🔬📰BIOASTER shares its comparison results of DNA extraction methods for 16S rRNA gene sequencing in the analysis of the human gut microbiome in collaboration with @biomerieux 🧬
More info: https://t.co/bKOMfbO8kP
@BIOASTER
presents a poster at ISMB/ECCB (July 23-27th) in Lyon, entitled “Comparative analysis of supervised integrative methods for #multiomics#data ” in collaboration with
@GatesMRI
July 25th -poster N°233!
2️⃣ Localisé à Gerland et coordonné par @Lyonbiopole, le "Biocluster français d’innovation en infectiologie" ou BCF2I, regroupera avec une approche One Health des leaders mondiaux des sciences de la vie, des PME innovantes, @UnivLyon1@CIRI_Lyon@BIOASTER@CHUdeLyon
[#LBPactu] 📢 Toute l'équipe de Lyonbiopôle se réjouie de cette grande nouvelle !
Le projet de #biocluster en #infectiologie BCF2I (Biocluster for Innovation in Infectious Diseases) a été labellisé hier par le Président de la République @EmmanuelMacron
https://t.co/TG9iPo1OAT
#France2030 : 4 nouveaux bioclusters et 12 nouveaux instituts hospitalo-universitaires et différentes infrastructures de recherche vont recevoir un soutien financier de la part de l’État pour accélérer la recherche et l’innovation en santé.
En savoir + 👉https://t.co/HKWHAV8D94